A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
The candidate malaria vaccine RTS,S/AS01 reduced episodes of both clinical and severe malaria in children 5 to 17 months of age by approximately 50% in an ongoing phase 3 trial. We studied infants 6 to 12 weeks of age recruited for the same trial.
Originalsprog | Engelsk |
---|---|
Tidsskrift | New England Journal of Medicine |
Vol/bind | 367 |
Udgave nummer | 24 |
Sider (fra-til) | 2284-95 |
Antal sider | 12 |
ISSN | 0028-4793 |
DOI | |
Status | Udgivet - 2012 |
ID: 43233798